THU0340 Adrenal Insufficiency During Glucocorticoid Treatment in Patients With Polymyalgia Reumatica or Giant Cell Arteritis

doi 10.1136/annrheumdis-2017-eular.6623
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Giant-Cell Arteritis and Polymyalgia Rheumatica

Annals of Internal Medicine
Internal MedicineMedicine
2003English

Infliximab Doesn't Work in Giant Cell Arteritis or Polymyalgia Rheumatica

BMJ
2007English

Hypothyroidism in Polymyalgia Rheumatica and Giant Cell Arteritis.

BMJ
1990English

ESR in Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1983English

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients With Giant Cell Arteritis

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Azathioprine in Giant Cell Arteritis/Polymyalgia Rheumatica: A Double-Blind Study.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1986English

Improving Glucocorticoid Replacement Profiles in Adrenal Insufficiency

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Associations Between Polymyalgia Rheumatica and Giant Cell Arteritis and 12 Cardiovascular Diseases

Heart
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy